Filing Details
- Accession Number:
- 0001654954-20-000269
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-10 14:13:12
- Reporting Period:
- 2020-01-08
- Accepted Time:
- 2020-01-10 14:13:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1540159 | Edesa Biotech Inc. | EDSA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1777988 | Carlo Sistilli | C/O Edesa Biotech Inc. 100 Spy Court Markham A6 L3R 5H6 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-01-08 | 2,436 | $4.11 | 2,436 | No | 4 | P | Indirect | Held by York-Cav Enterprises, Inc. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Held by York-Cav Enterprises, Inc. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Common Share Warrants (Right to Buy) | Acquisiton | 2020-01-08 | 1,827 | $0.00 | 1,827 | $4.80 |
| Common Shares | Common Share Warrants (Right to Buy) | Acquisiton | 2020-01-08 | 1,218 | $0.00 | 1,218 | $4.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,827 | 2020-07-08 | 2023-07-08 | No | 4 | P | Indirect |
| 1,218 | 2020-07-08 | 2020-11-08 | No | 4 | P | Indirect |
Footnotes
- The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
- York-Cav Enterprises, Inc. is partially owned by the reporting party.Mr. Sistilli disclaims beneficial ownership except to the extent of his precautionary interest therein.
- Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
- Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.
Billionaire Hedge Funds
